WuXi Biologics (Cayman) Inc. (2269.HK)

HKD 24.1

(5.7%)

Long Term Debt Summary of WuXi Biologics (Cayman) Inc.

WuXi Biologics (Cayman) Inc.'s latest annual long term debt in 2023 was 3.83 Billion CNY , up 29.78% from previous year.
WuXi Biologics (Cayman) Inc.'s latest quarterly long term debt in 2024 Q2 was 1.26 Billion CNY , down 0.0% from previous quarter.
WuXi Biologics (Cayman) Inc. reported annual long term debt of 2.95 Billion CNY in 2022, up 42.58% from previous year.
WuXi Biologics (Cayman) Inc. reported annual long term debt of 2.06 Billion CNY in 2021, down -17.34% from previous year.
WuXi Biologics (Cayman) Inc. reported quarterly long term debt of 1.26 Billion CNY for 2024 Q1, down -19.53% from previous quarter.
WuXi Biologics (Cayman) Inc. reported quarterly long term debt of 3.83 Billion CNY for 2023 FY, up 29.78% from previous quarter.

Annual Long Term Debt Chart of WuXi Biologics (Cayman) Inc. (2023 - 2014)

Historical Annual Long Term Debt of WuXi Biologics (Cayman) Inc. (2023 - 2014)

Year	Long Term Debt	Long Term Debt Growth
2023	3.83 Billion CNY	29.78%
2022	2.95 Billion CNY	42.58%
2021	2.06 Billion CNY	-17.34%
2020	2.5 Billion CNY	50.73%
2019	1.66 Billion CNY	1079.14%
2018	140.89 Million CNY	0.0%
2017	- CNY	-100.0%
2016	895.65 Million CNY	0.0%
2015	- CNY	0.0%
2014	- CNY	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	1.26 Billion CNY	0.0%
2024 Q1	1.26 Billion CNY	-19.53%
2023 FY	3.83 Billion CNY	29.78%
2023 Q3	3.83 Billion CNY	-0.79%
2023 Q4	3.83 Billion CNY	0.0%
2023 Q2	3.86 Billion CNY	0.0%
2023 Q1	3.86 Billion CNY	30.81%
2022 Q3	2.95 Billion CNY	53.3%
2022 Q1	1.92 Billion CNY	-6.99%
2022 FY	2.95 Billion CNY	42.58%
2022 Q4	2.95 Billion CNY	0.0%
2022 Q2	1.92 Billion CNY	0.0%
2021 Q3	2.06 Billion CNY	-37.38%
2021 FY	2.06 Billion CNY	-17.34%
2021 Q1	3.3 Billion CNY	32.0%
2021 Q4	2.06 Billion CNY	0.0%
2021 Q2	3.3 Billion CNY	0.0%
2020 Q4	2.5 Billion CNY	0.0%
2020 FY	2.5 Billion CNY	50.73%
2020 Q1	2.86 Billion CNY	72.38%
2020 Q2	2.85 Billion CNY	-0.38%
2020 Q3	2.5 Billion CNY	-12.23%
2019 FY	1.66 Billion CNY	1079.14%
2019 Q4	1.66 Billion CNY	0.0%
2019 Q3	1.66 Billion CNY	667.17%
2019 Q2	216.55 Million CNY	0.0%
2019 Q1	216.55 Million CNY	53.7%
2018 Q1	- CNY	0.0%
2018 Q4	140.89 Million CNY	0.0%
2018 Q3	- CNY	0.0%
2018 Q2	- CNY	0.0%
2018 FY	140.89 Million CNY	0.0%
2017 Q1	921.05 Million CNY	2.84%
2017 FY	- CNY	-100.0%
2017 Q4	- CNY	0.0%
2017 Q3	- CNY	-100.0%
2017 Q2	921.05 Million CNY	0.0%
2016 Q1	- CNY	0.0%
2016 Q4	895.65 Million CNY	0.0%
2016 FY	895.65 Million CNY	0.0%
2015 Q4	- CNY	0.0%
2015 FY	- CNY	0.0%
2014 FY	- CNY	0.0%

Peer Long Term Debt Comparison of WuXi Biologics (Cayman) Inc.

Name	Long Term Debt	Long Term Debt Difference
Uni-Bio Science Group Limited	30.61 Million HKD	-12411.6%
CK Life Sciences Int'l., (Holdings) Inc.	4.27 Billion HKD	10.365%